Digital & Decentralized Finance, Blockchain Daily News
              



Blockchain in Healthcare Will Live Up to the Hype Versus Reality for Stakeholders


With the healthcare industry increasingly going digital, blockchain technology provides the much-needed trust, security, and auditability for healthcare data on its intelligence journey, which allows blockchain to complement healthcare artificial intelligence (AI) and internet of things (IoT)-based data marketplace offerings. Early commercial success, mainly across select use cases such as health professional credentialing, medical billing management, personal health records (PHR), and pharma supply chain track-and-trace, will help this market cross $500 million by 2022 at a compound annual growth rate (CARG) of 61.40%. While payback may not be achieved for every dollar invested by 2022, a breakeven stage is expected.



"Health insurance payers, providers, and pharma companies are expected to adopt blockchain systems ahead of other healthcare industry stakeholders," said Kamaljit Behera, Senior Industry Analyst, Transformational Health. "In the future, distributed ledger technology (DLT) will be leveraged by telehealth vendors and tech giants such as Apple, Amazon, Google, and Microsoft to monetize data science and analytical services with innovative patient-centric care models."

Frost & Sullivan's recent analysis, Global Blockchain Technology Market in the Healthcare Industry, 2018–2022, examines key growth opportunities and highlights key success factors and strategic imperatives for blockchain commercial deployment consideration in the healthcare space by assessing commercial partnerships. It also analyzes best-practice case studies for the identified growth opportunities.

For further information on this analysis, please visit: http://frost.ly/3w3.

In an emerging marketplace, the most successful blockchain technology providers will be those that:

- Explore applications like healthcare data infrastructure, health data access, on-demand healthcare, pharma drug supply chain, and identity management.
- Become a part of prominent consortiums such as synoptic, Hashed Health (Professional Credential Exchange), Insureum, and MediBloc among others.
- Engage with healthcare buyers as they undertake a thorough assessment of vendor solutions to invest in or engage with the most promising options.
- Target the United States market with payer- and provider-focused blockchain applications and countries such as Estonia, the United Kingdom, Switzerland, and South Korea with Blockchain-based PHR and patient identity applications.
- Establish a collaborative ecosystem for exploring and developing focused use cases and governance standards for future commercial scalability and success.
- The large-scale commercial deployment of PHR application seems more feasible in Europe and Asia where the healthcare data vendor ecosystem is relatively less complex compared to the US market.
- The interplay between three emerging technologies, namely Blockchain, Artificial Intelligence and IoT, will further catalyze the space of innovation adoption and related applications in the healthcare realm.

Global Blockchain Technology Market in the Healthcare Industry, 2018–2022 is part of Frost & Sullivan's global Life Sciences Growth Partnership Service program.

About Frost & Sullivan
For over five decades, Frost & Sullivan has become world-renowned for its role in helping investors, corporate leaders and governments navigate economic changes and identify disruptive technologies, Mega Trends, new business models and companies to action, resulting in a continuous flow of growth opportunities to drive future success. Contact us: Start the discussion.
http://ww2.frost.com
http://www.frost.com

SOURCE Frost & Sullivan

Finyear & Chaineum

Lisez gratuitement le quotidien Finyear & sa newsletter quotidienne.
Recevez chaque matin par mail la newsletter Finyear, une sélection quotidienne des meilleures infos et expertises en finance digitale, corporate finance & crypto finance.

Read for free The daily newspaper Finyear & its daily newsletter.
Receive the Finyear's newsletter every morning by email, a daily snapshot of the best news and expertise in digital finance, corporate finance & crypto finance.

------------------------

Chaineum :
Fondée en 2015, Chaineum est une boutique STO offrant une expertise de premier plan en matière d’ICO et STO, avec une vision stratégique orientée tant vers le métier de ses clients que sur la technologie blockchain. A ce titre, Chaineum a participé à la mise en œuvre de bonnes pratiques dans le secteur (ICO Charter, Security Token Network).
La division services blockchain de Chaineum, développe la technologie Chaineum Segment, une blockchain privée orientée objets.

About Chaineum:
Founded in 2015, Chaineum is a STO Boutique with a strong expertise in ICO and STO, and a strategic focus on both its clients' business and blockchain technology. As such, Chaineum paved the way in the implementation of certain best practices in this sector (ICO Charter, Security Token Network).
Chaineum's blockchain services division, is developing Chaineum Segment technology, an object-oriented private blockchain.

-------------------------

No Offer, Solicitation, Investment Advice, or Recommendations

This website is for informational purposes only and does not constitute an offer to sell, a solicitation to buy, or a recommendation for any security, nor does it constitute an offer to provide investment advisory or other services by FINYEAR.
No reference to any specific security constitutes a recommendation to buy, sell or hold that security or any other security.
Nothing on this website shall be considered a solicitation or offer to buy or sell any security, future, option or other financial instrument or to offer or provide any investment advice or service to any person in any jurisdiction.
Nothing contained on the website constitutes investment advice or offers any opinion with respect to the suitability of any security, and the views expressed on this website should not be taken as advice to buy, sell or hold any security. In preparing the information contained in this website, we have not taken into account the investment needs, objectives and financial circumstances of any particular investor.
This information has no regard to the specific investment objectives, financial situation and particular needs of any specific recipient of this information and investments discussed may not be suitable for all investors.
Any views expressed on this website by us were prepared based upon the information available to us at the time such views were written. Changed or additional information could cause such views to change.
All information is subject to possible correction. Information may quickly become unreliable for various reasons, including changes in market conditions or economic circumstances.

Vendredi 29 Novembre 2019
Notez


Nouveau commentaire :
Twitter

Your email address will not be published. Required fields are marked *
Votre adresse de messagerie ne sera pas publiée. Les champs obligatoires sont indiqués avec *

Finyear: latest news, derniers articles